Yesterday, Health Canada released a statement on the Smith case, the result being they are now allowing licensed producers under the MMPR to manufacture cannabis oil for sale to Canadians. This is the first time a so-called “derivative” has been permitted for sale in Canada.
The changes are effective immediately, however licensed producers who have a licence to cultivate have to achieve a “supplemental licence” to start producing and selling cannabis oil to registered clients (see Section 56 Class Exemption for LP’s).
There are restrictions being imposed, notably the THC concentration must be no greater than 3% w/v (30 mg THC per 1mL oil). However, there does not seem to be a restriction on the concentration of other biomarkers such as CBD. There are also many extra requirements for labelling and packaging, but they’re unimportant details at this point. Pharmaceutical in nature.
What is particularly exciting is the allowance of capsules such as gelatin capsules containing cannabis oil. Similar to fish oil capsules. Now, the cannabis oil capsules cannot contain any flavour or scent, but there doesn’t seem to be a restriction on excipients at this time. For example, if the oil is quite thick, a diluent could be used to make filling easier. However, we have yet to understand excipient use.
All of this means that supercritical extraction techniques (and machinery) can now be legally imported into Canada and used by licensed producers to manufacture cannabis oil. Why this is exciting for the industry, is it is a positive step forward allowing the free sale of medical marijuana in dosage forms that are better suited to the health of Canadians. We wouldn’t give our children cigarettes; we wouldn’t give them a joint to smoke. Gel caps are a healthier solution that help with dosage compliance.
There are other changes, such as allowing individuals to make their own oils, so long as they don’t use organic solvents.
At the same time, Health Canada also released a variety of statements and bulletins covering a range of topics. For example, to date it has been suggested that a producer in Canada could import finished product grown in another country, rather than grow domestically; however, a recent bulletin suggests Health Canada would not allow this. It will take some time to digest everything they have published, please stay tuned.
– See more at: http://www.nhpconsulting.ca/blog/cannabis-oil-allowed#sthash.whuX43qa.dpuf